MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

18.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential ↗
As the new business cycle gets started, here are some biotech stocks with potential that investors should pay attention to. 
Via InvestorPlace
News headline image
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating ↗
Axsome Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
News headline image
Despite its impressive fundamentals, NASDAQ:AMPH remains undervalued. ↗
For those who appreciate value investing, AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) is a compelling option with its solid fundamentals. 
Via Chartmill
News headline image
Unlocking the Growth Potential of NASDAQ:AMPH. ↗
Exploring AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH)'s growth characteristics. 
Via Chartmill
News headline image
What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition ↗
Vitamins may not be a miracle cure, but combined with exercise and a healthy diet, they have the potential to greatly improve health and wellness. It’s no wonder vitamin supplements are a multi-billion... 
Via Benzinga
News headline image
NASDAQ:AMPH is not too expensive for the growth it is showing. ↗
Looking for growth without the hefty price tag? Consider NASDAQ:AMPH. 
Via Chartmill
News headline image
Why NASDAQ:AMPH is Poised for High Growth. ↗
Exploring AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH)'s growth characteristics. 
Via Chartmill
News headline image
Why AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) qualifies as a high growth stock. ↗
Is AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) suited for growth investing? 
Via Chartmill
News headline image
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here. 
Via Benzinga
News headline image
Cassava Sciences Stock Continues Showing Rising Relative Strength ↗
Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level. 
Via Investor's Business Daily
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
News headline image
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Via ACCESSWIRE
News headline image
Should you consider NASDAQ:AMPH for growth investing? ↗
Is AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) suited for growth investing? 
Via Chartmill
News headline image
Why NASDAQ:AMPH qualifies as a high growth stock. ↗
Why the growth investor may take a look at AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH). 
Via Chartmill
News headline image
Exploring NASDAQ:AMPH's CANSLIM characteristics. ↗
Should you consider AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) for growth investing? 
Via Chartmill
News headline image
Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study ↗
On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before. 
Via Investor's Business Daily
News headline image
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher ↗
On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. 
Via Investor's Business Daily
News headline image
3 Reasons Why Amphastar Is a Great Growth Stock ↗
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great... 
Via Talk Markets
News headline image
3 Stocks at the Forefront of Medical Innovation ↗
Boring businesses and industries typically show new faces when technology comes around; today, these biotech stocks are leading the way. 
Via InvestorPlace
News headline image
Tarsus Pharmaceuticals Stock Scores Relative Strength Rating Upgrade ↗
On Thursday, Tarsus Pharmaceuticals stock reached a key technical milestone, seeing its Relative Strength Rating jump to 91 from 84. 
Via Investor's Business Daily
News headline image
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating ↗
TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. 
Via Investor's Business Daily
News headline image
Exploring growth characteristics of AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH). ↗
Why AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) qualifies as a high growth stock. 
Via Chartmill
News headline image
Evaluating NASDAQ:AMPH for Growth Investment Opportunities. ↗
High growth, ROE and relative strength for AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH), growth investors may appreciate this. 
Via Chartmill
News headline image
These Three Biotech Stocks Are Trading At A Discount ↗
Investors exposed to the biotech sector have seen mixed results this year. 
Via Talk Markets
News headline image
Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
Via ACCESSWIRE
News headline image
Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade ↗
Amphastar Pharmaceuticals stock saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before. 
Via Investor's Business Daily
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Via ACCESSWIRE
News headline image
7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
Via InvestorPlace
News headline image
Recap: Amphastar Pharma Q3 Earnings ↗
 
Via Benzinga
News headline image
Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story